Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients

Abstract To date, only few data concerning the biologically active, free form of testosterone (FT) are available in metastatic prostate cancer (mPC) and the impact of FT on disease, therapy and outcome is largely unknown. We retrospectively studied the effect of docetaxel on FT and total testosteron...

Full description

Bibliographic Details
Main Authors: Paula Kappler, Michael A. Morgan, Philipp Ivanyi, Stefan J. Brunotte, Arnold Ganser, Christoph W. M. Reuter
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-95874-y